Beyond major marijuana developments in the U.S. at the federal and state levels this year, momentum for drug policy reform continued to build across many parts of the globe in 2023. From the issuance of the first licenses in the European Union for nonprofit cannabis associations to the EU’s largest economy taking steps toward legalizing marijuana for adults, a number of countries, especially in Europe and South America, marked drug reform milestones in the past year. Yet 2023 also saw a rash of… Read more.
Your daily dose of news & information.
Local government officials in the Swiss capital of Bern are discussing the possibility of launching a pilot program to study the effects of legal cocaine sales on the general public. According to Reuters, legislators in the Bern Parliament have proposed the idea as a potential solution to increased cocaine usage in a country already infamous for some of the highest levels of cocaine use in Europe. The discussion began just weeks after a select few Swiss cities, Bern included, launched a… Read more.
Curt Dalton of Cannabis.net once asked, are you buying or selling the European cannabis hype? While the EU may grow to be the biggest legal cannabis market in the word, with that growth will come the biggest illicit or black market in the world as well. As metioned in the article, "With a Gun to My Head, Here is the One Cannabis Investment I Would Make Right Now", is South America a much better choice in the long run for investors due… Read more.
Switzerland will allow Europe’s first non-medical cannabis dispensaries to open and operate as part of a study to examine how controlled access to legal cannabis may affect health and consumption patterns of regular cannabis consumers. An announcement was made Friday about “Grashaus Projects” by German CBD and cannabinoid research company Sanity Group which said that in tandem with the Swiss Institute for Addiction and Health Research, their initiative to dispense legal cannabis to a small area in Switzerland called Basel-Landschaft had been… Read more.
The Zurich authorities have given the green light to a groundbreaking initiative to evaluate the potential advantages of legalizing cannabis. Starting this summer, 2,100 Zurich citizens will be granted permission to purchase controlled amounts of the substance from designated dispensaries, pharmacies, and social hubs scattered throughout the city. This trial period will serve as a test case to determine the possible social and economic benefits of regulating the sale and consumption of cannabis. In collaboration with the University of Zurich, the study organizers will require… Read more.
Switzerland’s government has approved a trial to legalize the sale and consumption of cannabis and assess the social and economic benefits of regulating cannabis products, CNBC reports. Starting this summer, a test group of 2,100 Zurich residents will be allowed to purchase regulated doses of cannabis for personal use from pharmacies, dispensaries, and social clubs in the city. As part of the study, participants will be expected to answer a questionnaire every six months on their cannabis consumption habits and health effects. The study is conducted in collaboration… Read more.
Switzerland’s government is one step closer to its yearslong effort to launch a trial program involving the sale and consumption of recreational cannabis. Called “Züri Can – Cannabis with Responsibility,” the study will involve only Zurich and is intended to provide a scientific basis for the development of the country’s cannabis policies. The study was expected to start in autumn 2022 but was delayed because the Federal Office of Public Health and the Cantonal Ethics Committee had yet to give their approval. Only… Read more.